is trulicity a glp-1 drug Lawsuit [2026] Trulicity (dulaglutide): Injectable GLP-1 RA

doi: 10.3390/ijms22041679 179 LiangYJYangWX

The effect of GLP-1 depends on blood glucose levels since it can only potentiate glucose-stimulated insulin secretion from islet beta cells in the hyperglycemic state rather than in the normal blood glucose state (95, 96)

EXSCEL Study Group

doi: 10.1056/NEJMsr1606602 [DOI] [PMC free article] [PubMed] [Google Scholar] 7

Both formulations are administered as once-weekly SC injections due to the long half-life of Semaglutide (approximately one week)

Loos, a professor at the University of Copenhagen and affiliated with a research center supported by the Novo Nordisk Foundation (the maker of Wegovy and Ozempic), noted, "The current model explains only 25% of the variability, and further research is needed to uncover the remaining 75%." However, she also expressed optimism, stating, "By combining genetic and clinical information, the era of personalized medicine, where we can select the best drug for each patient, may be upon us."